MarginsXMarginsX
Home › Markets › CRLBF

Cresco Labs Inc. (CRLBF)

CRLBF is quoted over the counter, not listed on an exchange. Cresco Labs Inc. files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.

Close · November 16, 2026
$0.4850
-3.0% on the day
1-year return
-49.8%
Market cap
$243.8M
Micro cap. From the Nov 16, 2026 close × 502.8M shares (TMX list of CSE companies, Nov 13, 2026)
P/E and P/S
Net loss over the period · 0.4×
On fiscal year to December 31, 2025 (40-F)

Closes: Yahoo Finance daily closes, last bar 2026-11-16.

Profile

FieldValue
TickerCRLBF, quoted over the counter
SEC CIK0001832928
OTC Markets tierOTCQX (price source, 2026-11-13)
SEC industry codeMedicinal Chemicals & Botanical Products
Business addressChicago, IL
Incorporated inBC

Warning signs

Cash runway
Cash-flow positive
$57.9M cash at December 31, 2025
Share count, 1 year
See the dilution note
Going-concern doubt
No
40-F filed March 6, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.40-F 2026-03-06
Cash and burn$57.9M cash; operating cash flow $18.2M a quarter.Report 2025-12-31
Shares outstanding502,755,064 (2025-12-31). the newest SEC cover-page count is from 2025-12-31; shares issued since then are not in these figures.Cover page 2025-12-31
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorBaker Tilly US, LLP, Chicago, Illinois, United StatesPCAOB Form AP 2026-04-07
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Annual results

Fiscal yearRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
FY 2025
2025-12-31
$655.8M-$135.4M$72.9M$57.9M$431.2M$655.8M40-F 2026-03-06
FY 2024
2024-12-31
$724.3M-$74.4M$132.5M$137.6M$475.3M$724.3M40-F 2026-03-06
FY 2023
2023-12-31
$770.9M-$175.5M$58.6M$103.4M$511.5M$770.9M40-F 2025-03-14
FY 2022
2022-12-31
$842.7M-$212.0M$18.7M$121.5M$11.0M$842.7M40-F 2024-03-18
FY 2021
2021-12-31
$821.7M-$319.6M$14.5M$223.5M$19.9M$821.7M40-F 2023-03-22
FY 2020
2020-12-31
$476.3M-$102.2M-$7.8M$136.3M$25.9M$476.3M40-F 2022-04-05
FY 2019
2019-12-31
$128.5M-$43.2M-$25.2M$49.1M$550K$128.5M40-F/A 2021-04-29

From SEC XBRL company facts (annual reports only: 20-F or 40-F). Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest annual report40-F2026-03-06
Latest quarterly / interim6-K2026-11-06

Source: SEC EDGAR submissions feed, 94 recent filings. All filings on EDGAR.

The full dossier has every filing, quarterly and annual financials, the health record and a price chart.

Open the full dossier